Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-γ2 in Korean diabetic and obese subjects

被引:86
作者
Oh, EY
Min, KM
Chung, JH
Min, YK
Lee, MS
Kim, KW
Lee, MK [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Med, Div Endocrinol & Metab,Samsung Med Ctr, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul 135710, South Korea
关键词
D O I
10.1210/jc.85.5.1801
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) are a nuclear hormone receptor superfamily of ligand-activated transcription factors, and the PPAR gamma subtype regulates adipocyte differentiation, lipid metabolism, and insulin sensitivity. There have been several reports on the relationship between the PPAR gamma 2 Pro(12)Ala genotype and obesity or diabetes in Caucasians. The objective of this study was to examine the relationship between this mutation and obesity or diabetes in Korean subjects. Two hundred and twenty-nine Korean subjects, including 111 obese subjects (body mass index, >25 kg/m(2)) were included in this study. One hundred and eleven subjects had normal glucose tolerance, 60 had impaired glucose tolerance, and 58 had diabetes mellitus. We evaluated these subjects for the Pro(12)Ala mutation in the PPAR gamma gene using PCR-restriction fragment length polymorphism. Allele frequencies of the Pro(12)Ala missense mutation of PPAR gamma 2 were not different among Korean subjects with normal glucose tolerance (qAla = 0.045), those with impaired glucose tolerance (qAla = 0.033), and those with diabetes mellitus (qAla = 0.043; P > 0.05). Allele frequencies of PPAR gamma 2 Ala in obese subjects (qAla = 0.036) were not significantly different from those in nonobese subjects (qAla = 0.047). These results suggest that the Pro(12)Ala mutation in PPAR gamma is not associated with either diabetes or obesity and may not be an important determinant of obesity or diabetes in Korean subjects.
引用
收藏
页码:1801 / 1804
页数:4
相关论文
共 21 条
[1]   Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations [J].
Beamer, BA ;
Yen, CJ ;
Andersen, BE ;
Muller, D ;
Elahi, D ;
Cheskin, LJ ;
Andres, R ;
Roth, J ;
Shuldiner, AR .
DIABETES, 1998, 47 (11) :1806-1808
[2]   Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[3]   Differential activation of adipogenesis by multiple PPAR isoforms [J].
Brun, RP ;
Tontonoz, P ;
Forman, BM ;
Ellis, R ;
Chen, J ;
Evans, RM ;
Spiegelman, BM .
GENES & DEVELOPMENT, 1996, 10 (08) :974-984
[4]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287
[5]   Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 [J].
Elbrecht, A ;
Chen, YL ;
Cullinan, CA ;
Hayes, N ;
Leibowitz, MD ;
Moller, DE ;
Berger, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) :431-437
[6]  
ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
[7]   Effects of troglitazone - A new hypoglycemic agents in patients with NIDDM poorly controlled by diet therapy [J].
Iwamoto, Y ;
Kosaka, K ;
Kuzuya, T ;
Akanuma, Y ;
Shigeta, Y ;
Kaneko, T .
DIABETES CARE, 1996, 19 (02) :151-156
[8]   A PROSTAGLANDIN J(2) METABOLITE BINDS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AND PROMOTES ADIPOCYTE DIFFERENTIATION [J].
KLIEWER, SA ;
LENHARD, JM ;
WILLSON, TM ;
PATEL, I ;
MORRIS, DC ;
LEHMANN, JM .
CELL, 1995, 83 (05) :813-819
[9]   Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism [J].
Latruffe, N ;
Vamecq, J .
BIOCHIMIE, 1997, 79 (2-3) :81-94
[10]   METABOLIC EFFECTS OF TROGLITAZONE ON FRUCTOSE-INDUCED INSULIN-RESISTANCE IN THE RAT [J].
LEE, MK ;
MILES, PDG ;
KHOURSHEED, M ;
GAO, KM ;
MOOSSA, AR ;
OLEFSKY, JM .
DIABETES, 1994, 43 (12) :1435-1439